Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACM Research, Inc.ACMR · Entity 3926 | Director | August 23, 2021 | August 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACM Research, Inc.
Report date August 23, 2021 · Filed August 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,146,170 |
Last balance in matching sequence
After 2021-08-24 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2021-08-23 · Sale · Disposed 35,136 · Balance 1,390,799 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 of this Form 4. F3: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Row 2 · 2021-08-24 · Sale · Disposed 33,000 · Balance 1,357,799 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F3: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Row 3 · 2021-08-24 · Sale · Disposed 200,000 · Balance 1,157,799 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.80 to $88.37, inclusive. F3: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Row 4 · 2021-08-24 · Sale · Disposed 11,629 · Balance 1,146,170 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F3: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd.
F2: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 of this Form 4.
F3: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
F4: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.80 to $88.37, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2021 Filed Aug 25, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 11,629 | $88.97 | $1,034,634.46 |
DisclosureSEC source: 0001140361-21-029285 · form4.xml · nonDerivative · entry 4 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,146,170 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 200,000 | $88.11 | $17,621,740.00 |
DisclosureSEC source: 0001140361-21-029285 · form4.xml · nonDerivative · entry 3 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,157,799 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.80 to $88.37, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 33,000 | $86.08 | $2,840,514.60 |
DisclosureSEC source: 0001140361-21-029285 · form4.xml · nonDerivative · entry 2 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,357,799 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 35,136 | $85.03 | $2,987,564.89 |
DisclosureSEC source: 0001140361-21-029285 · form4.xml · nonDerivative · entry 1 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,390,799 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 of this Form 4. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 18, 2021 Filed Aug 21, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,476 | $86.28 | $127,342.79 |
DisclosureSEC source: 0001140361-21-029058 · form4.xml · nonDerivative · entry 2 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,425,935 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.00 to $86.65, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 18, 2021 Filed Aug 21, 2021 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 25,136 | $85.06 | $2,137,960.08 |
DisclosureSEC source: 0001140361-21-029058 · form4.xml · nonDerivative · entry 1 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,427,411 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 of this Form 4. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 13, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 3,623 | $85.10 | $308,311.50 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 6 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,452,547 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F8 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.23, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 12, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 20,000 | $85.33 | $1,706,532.00 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 5 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,456,170 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F7 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $86.00, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 11, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 2,500 | $90.05 | $225,116.00 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 4 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,476,170 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F6 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.25, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 11, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,600 | $89.17 | $142,679.52 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 3 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,478,670 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F5 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.665 to $89.50, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 11, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 358 | $86.15 | $30,840.48 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 2 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,480,270 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.02 to $86.40, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| August 11, 2021 Filed Aug 14, 2021 00:07 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 25,542 | $85.53 | $2,184,530.63 |
DisclosureSEC source: 0001140361-21-028330 · form4.xml · nonDerivative · entry 1 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,480,628 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $86.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5, 6, 7 and 8 of this Form 4. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which designated the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 14,920 | $75.00 | $1,119,000.00 |
DisclosureSEC source: 0001140361-20-029242 · form4.xml · nonDerivative · entry 4 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,506,170 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 26,892 | $75.08 | $2,019,051.36 |
DisclosureSEC source: 0001140361-20-029242 · form4.xml · nonDerivative · entry 3 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,521,090 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F5 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.50, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,699 | $76.10 | $129,293.90 |
DisclosureSEC source: 0001140361-20-029242 · form4.xml · nonDerivative · entry 2 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,547,982 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.00 to $76.13, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 82,454 | $75.30 | $6,208,786.20 |
DisclosureSEC source: 0001140361-20-029242 · form4.xml · nonDerivative · entry 1 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,549,681 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 of this Form 4. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 17, 2020 Filed Dec 17, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 3,214 | $75.02 | $241,114.28 |
DisclosureSEC source: 0001140361-20-028759 · form4.xml · nonDerivative · entry 3 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,632,135 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F5 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.14, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 11,218 | $76.03 | $852,904.54 |
DisclosureSEC source: 0001140361-20-028759 · form4.xml · nonDerivative · entry 2 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,635,349 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F4 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.00 to $76.25, inclusive. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 19,603 | $75.29 | $1,475,909.87 |
DisclosureSEC source: 0001140361-20-028759 · form4.xml · nonDerivative · entry 1 Xiang Yinan · CIK 0001721583 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,646,567 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 of this Form 4. F3 · ownership.nature: These shares are owned by Shanghai Science and Technology Venture Capital Co., Ltd., which exercised a contractual right in designating the reporting person to the board of directors of the Issuer. The reporting person disclaims beneficial ownership of the shares owned by Shanghai Science and Technology Venture Capital Co., Ltd. except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.